Clinical Trial Update: Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the Group ACYW135 meningococcal polysaccharide vaccine (NCT01661738) showing the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• Group ACYW135 Meningococcal Polysaccharide Vaccine 002 (Meningococcal polysaccharide vaccine (Group ACYW135))

Snippet

Sponsor: Hualan Biological Engineering, Inc. | Conditions: Meningitis | Phase 2 | Status: COMPLETED